STAAR SURGICAL CO (STAA)
US8523123052 - Common Stock
STAA gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making STAA a very profitable company, without any liquidiy or solvency issues. STAA is growing strongly while it is still valued neutral. This is a good combination! With these ratings, STAA could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year STAA was profitable.
In the past year STAA had a positive cash flow from operations.
STAA had positive earnings in each of the past 5 years.
In the past 5 years STAA always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of STAA (4.05%) is better than 78.61% of its industry peers.
STAA has a better Return On Equity (5.09%) than 77.01% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.05%, STAA is in the better half of the industry, outperforming 74.87% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for STAA is in line with the industry average of 8.19%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.05% | ||
| ROE | 5.09% | ||
| ROIC | 4.05% |
ROA(3y)6.93%
ROA(5y)5.97%
ROE(3y)8.89%
ROE(5y)7.69%
ROIC(3y)7.4%
ROIC(5y)5.91%
1.3 Margins
With a decent Profit Margin value of 6.38%, STAA is doing good in the industry, outperforming 77.54% of the companies in the same industry.
STAA's Profit Margin has improved in the last couple of years.
STAA has a Operating Margin of 7.53%. This is in the better half of the industry: STAA outperforms 74.87% of its industry peers.
STAA's Operating Margin has improved in the last couple of years.
STAA has a Gross Margin of 78.73%. This is amongst the best in the industry. STAA outperforms 91.44% of its industry peers.
In the last couple of years the Gross Margin of STAA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.53% | ||
| PM (TTM) | 6.38% | ||
| GM | 78.73% |
OM growth 3Y27.96%
OM growth 5Y10.36%
PM growth 3Y22.42%
PM growth 5Y10.43%
GM growth 3Y2.67%
GM growth 5Y1.21%
2. Health
2.1 Basic Checks
STAA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for STAA has been increased compared to 1 year ago.
Compared to 5 years ago, STAA has more shares outstanding
STAA has a better debt/assets ratio than last year.
2.2 Solvency
STAA has an Altman-Z score of 8.15. This indicates that STAA is financially healthy and has little risk of bankruptcy at the moment.
STAA has a better Altman-Z score (8.15) than 86.63% of its industry peers.
There is no outstanding debt for STAA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.15 |
ROIC/WACC0.44
WACC9.21%
2.3 Liquidity
STAA has a Current Ratio of 5.99. This indicates that STAA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of STAA (5.99) is better than 81.28% of its industry peers.
STAA has a Quick Ratio of 5.38. This indicates that STAA is financially healthy and has no problem in meeting its short term obligations.
STAA's Quick ratio of 5.38 is amongst the best of the industry. STAA outperforms 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.99 | ||
| Quick Ratio | 5.38 |
3. Growth
3.1 Past
STAA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.71%, which is quite impressive.
STAA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 43.10% yearly.
STAA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.00%.
The Revenue has been growing by 21.06% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)62.71%
EPS 3Y71%
EPS 5Y43.1%
EPS Q2Q%26.67%
Revenue 1Y (TTM)10%
Revenue growth 3Y25.4%
Revenue growth 5Y21.06%
Sales Q2Q%10.31%
3.2 Future
Based on estimates for the next years, STAA will show a very strong growth in Earnings Per Share. The EPS will grow by 28.86% on average per year.
STAA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.26% yearly.
EPS Next Y22.97%
EPS Next 2Y16.79%
EPS Next 3Y23.39%
EPS Next 5Y28.86%
Revenue Next Year6.35%
Revenue Next 2Y8.99%
Revenue Next 3Y10.89%
Revenue Next 5Y14.26%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 25.85, the valuation of STAA can be described as expensive.
STAA's Price/Earnings ratio is a bit cheaper when compared to the industry. STAA is cheaper than 79.68% of the companies in the same industry.
STAA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.73.
With a Price/Forward Earnings ratio of 30.33, STAA can be considered very expensive at the moment.
74.33% of the companies in the same industry are more expensive than STAA, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.83. STAA is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.85 | ||
| Fwd PE | 30.33 |
4.2 Price Multiples
STAA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. STAA is cheaper than 71.66% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of STAA indicates a somewhat cheap valuation: STAA is cheaper than 75.94% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 46.51 | ||
| EV/EBITDA | 29.12 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
STAA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as STAA's earnings are expected to grow with 23.39% in the coming years.
PEG (NY)1.13
PEG (5Y)0.6
EPS Next 2Y16.79%
EPS Next 3Y23.39%
5. Dividend
5.1 Amount
STAA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
STAAR SURGICAL CO
NASDAQ:STAA (12/20/2024, 8:00:00 PM)
After market: 24.82 0 (0%)24.82
-0.16 (-0.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners93.48%
Inst Owner Change2.85%
Ins Owners0.51%
Ins Owner Change0.66%
Market Cap1.22B
Analysts79
Price Target43.84 (76.63%)
Short Float %5.64%
Short Ratio4.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)83.99%
Min EPS beat(2)47.54%
Max EPS beat(2)120.44%
EPS beat(4)3
Avg EPS beat(4)55.01%
Min EPS beat(4)-26.79%
Max EPS beat(4)120.44%
EPS beat(8)6
Avg EPS beat(8)58.64%
EPS beat(12)9
Avg EPS beat(12)58.96%
EPS beat(16)13
Avg EPS beat(16)176%
Revenue beat(2)1
Avg Revenue beat(2)0.95%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.96%
Revenue beat(4)2
Avg Revenue beat(4)0.25%
Min Revenue beat(4)-1.46%
Max Revenue beat(4)1.96%
Revenue beat(8)3
Avg Revenue beat(8)0.28%
Revenue beat(12)4
Avg Revenue beat(12)0.05%
Revenue beat(16)7
Avg Revenue beat(16)1.96%
PT rev (1m)-13.26%
PT rev (3m)-15.8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-103.7%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.82%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.41%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.85 | ||
| Fwd PE | 30.33 | ||
| P/S | 3.58 | ||
| P/FCF | 46.51 | ||
| P/OCF | 25.99 | ||
| P/B | 2.86 | ||
| P/tB | 2.87 | ||
| EV/EBITDA | 29.12 |
EPS(TTM)0.96
EY3.87%
EPS(NY)0.82
Fwd EY3.3%
FCF(TTM)0.53
FCFY2.15%
OCF(TTM)0.95
OCFY3.85%
SpS6.92
BVpS8.69
TBVpS8.65
PEG (NY)1.13
PEG (5Y)0.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.05% | ||
| ROE | 5.09% | ||
| ROCE | 5.45% | ||
| ROIC | 4.05% | ||
| ROICexc | 8.11% | ||
| ROICexgc | 8.17% | ||
| OM | 7.53% | ||
| PM (TTM) | 6.38% | ||
| GM | 78.73% | ||
| FCFM | 7.71% |
ROA(3y)6.93%
ROA(5y)5.97%
ROE(3y)8.89%
ROE(5y)7.69%
ROIC(3y)7.4%
ROIC(5y)5.91%
ROICexc(3y)19.04%
ROICexc(5y)16.2%
ROICexgc(3y)19.35%
ROICexgc(5y)16.56%
ROCE(3y)9.97%
ROCE(5y)7.99%
ROICexcg growth 3Y8.98%
ROICexcg growth 5Y-4.52%
ROICexc growth 3Y9.85%
ROICexc growth 5Y-3.69%
OM growth 3Y27.96%
OM growth 5Y10.36%
PM growth 3Y22.42%
PM growth 5Y10.43%
GM growth 3Y2.67%
GM growth 5Y1.21%
F-Score5
Asset Turnover0.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 362.25% | ||
| Cap/Sales | 6.08% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 149.7% | ||
| Profit Quality | 120.78% | ||
| Current Ratio | 5.99 | ||
| Quick Ratio | 5.38 | ||
| Altman-Z | 8.15 |
F-Score5
WACC9.21%
ROIC/WACC0.44
Cap/Depr(3y)377.17%
Cap/Depr(5y)335.52%
Cap/Sales(3y)5.98%
Cap/Sales(5y)5.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.71%
EPS 3Y71%
EPS 5Y43.1%
EPS Q2Q%26.67%
EPS Next Y22.97%
EPS Next 2Y16.79%
EPS Next 3Y23.39%
EPS Next 5Y28.86%
Revenue 1Y (TTM)10%
Revenue growth 3Y25.4%
Revenue growth 5Y21.06%
Sales Q2Q%10.31%
Revenue Next Year6.35%
Revenue Next 2Y8.99%
Revenue Next 3Y10.89%
Revenue Next 5Y14.26%
EBIT growth 1Y37.75%
EBIT growth 3Y60.47%
EBIT growth 5Y33.61%
EBIT Next Year87.86%
EBIT Next 3Y54.22%
EBIT Next 5Y48.17%
FCF growth 1Y16.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.08%
OCF growth 3Y-11.35%
OCF growth 5Y2.71%